Systemic therapy and overall survival (OS) in patients (pts) with brain metastases from HER2-positive (HER2+) metastatic breast cancer (MBC).Rupert Bartsch, G. Steger, Ursula Pluschnig et al.|Journal of Clinical Oncology|2011Cited by 1